HG146
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HG146, covering 2024-10-10 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma [Phase 2]